Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, talks about the overwhelmingly positive feedback he has received from his colleagues about the significance of VBID, even when factoring in the suggested limitations from the myocardial infarction study.
In this segment, Dr. Choudhry discusses how the rigorous research methods that were applied in this VBID study proved valuable in several ways that transcends cost, such as highlighting the magnitude of nonadherence, and the need for physicians to understand that their work isn’t done once they’ve made the decision to prescribe.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More